Oramed Pharmaceuticals Inc ORMP
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2002-04-01 |
| Shares Out. | 40,930,000 |
| Website | oramed.com/ ↗ |
| Phone | 16468441164 |
| Employees | 13 |
| Net Income | $38.3M |
| Free Cash Flow | -$73.5M |
| Total Assets | $268.8M |
| Total Liabilities | $30.6M |
| Equity | $238.3M |
About Oramed Pharmaceuticals Inc
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Oramed Pharmaceuticals Inc is a publicly traded company under the ticker symbol ORMP on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2025-06-01)